Axar.Az Logo

Samsung will also produce cancer drugs

Home page World
12 Punto 14 Punto 16 Punto 18 Punto

Samsung Biologics Co Ltd said on Monday it would continue its partnership with AstraZeneca Plc on manufacturing biopharmaceuticals. reports that Samsung said production of drug substance and drug products is valued at about $380 million, up from the initial $331 million after the companies expanded the deal this year in May 2021.

The company said it would start to manufacture a cancer immunotherapy product from next year along with AstraZeneca’s COVID-19 long-acting antibody (LAAB) combination, AZD7442.

Samsung Biologics CEO John Rim said, “We are delighted to continue expanding our strategic collaboration with AstraZeneca, a valuable partner we have witnessed first-hand to have a strong commitment to saving lives of patients”.

2021.12.14 / 15:12
See also

Day 223: Russia announces Ukrainian losses

Shoigu announced the number of people who joined the army

Razuvayev: The West is arming Yerevan, and will start a war

A terrorist attack was committed in Somalia: 36 dead

This news about Armenia is nonsense

Kyiv officially refused to negotiate with Putin

This is the true face of the US - Iran

Hulusi Akar came to Azerbaijan

Chechnya will celebrate Putin's birthday

Zelensky hits back as Elon Musk sets up Twitter poll

Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla